Stock Track | Certara Soars 5% Intraday on Barclays Overweight Rating and Investor Conference Announcements

Stock Track

02/28

Certara, Inc. (CERT) saw its stock price soar 5.00% during intraday trading on Friday, marking a significant upward movement for the biosimulation software company.

The price surge appears to be driven by two positive developments. First, Barclays maintained its Overweight rating on Certara, indicating continued analyst confidence in the company's prospects. Second, Certara announced that its management will participate in several upcoming investor conferences, including the TD Cowen 46th Annual Health Care Conference, Leerink Global Healthcare Conference, and Barclays 28th Annual Global Healthcare Conference.

These announcements typically generate increased investor interest and visibility for companies, potentially explaining the buying pressure that led to Certara's substantial intraday gain.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1129556173"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1129556173\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1129556173?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-28 02:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1129556173","market":"nz","top_or_hot":-1,"title":"Stock Track | Certara Soars 5% Intraday on Barclays Overweight Rating and Investor Conference Announcements","media":"Stock Track","content":"<p>Certara, Inc. (CERT) saw its stock price soar 5.00% during intraday trading on Friday, marking a significant upward movement for the biosimulation software company.</p><p>The price surge appears to be driven by two positive developments. First, Barclays maintained its Overweight rating on Certara, indicating continued analyst confidence in the company's prospects. Second, Certara announced that its management will participate in several upcoming investor conferences, including the TD Cowen 46th Annual Health Care Conference, Leerink Global Healthcare Conference, and Barclays 28th Annual Global Healthcare Conference.</p><p>These announcements typically generate increased investor interest and visibility for companies, potentially explaining the buying pressure that led to Certara's substantial intraday gain.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Certara Soars 5% Intraday on Barclays Overweight Rating and Investor Conference Announcements</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Certara Soars 5% Intraday on Barclays Overweight Rating and Investor Conference Announcements\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-28 02:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Certara, Inc. (CERT) saw its stock price soar 5.00% during intraday trading on Friday, marking a significant upward movement for the biosimulation software company.</p><p>The price surge appears to be driven by two positive developments. First, Barclays maintained its Overweight rating on Certara, indicating continued analyst confidence in the company's prospects. Second, Certara announced that its management will participate in several upcoming investor conferences, including the TD Cowen 46th Annual Health Care Conference, Leerink Global Healthcare Conference, and Barclays 28th Annual Global Healthcare Conference.</p><p>These announcements typically generate increased investor interest and visibility for companies, potentially explaining the buying pressure that led to Certara's substantial intraday gain.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CERT","symbol_name":"Certara, Inc.","start_time":0,"source_url":"","article_id":"1129556173","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1129556173","pubTimestamp":1772215212,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Certara, Inc. (CERT) saw its stock price soar 5.00% during intraday trading on Friday, marking a significant upward movement for the biosimulation software company.The price surge appears to be...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CERT":"Certara, Inc."},"translate_title":"个股追踪|Certara盘中大涨5%，因巴克莱跑赢大盘评级及投资者会议公告","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CERT":1},"content_text":"Certara, Inc. (CERT) saw its stock price soar 5.00% during intraday trading on Friday, marking a significant upward movement for the biosimulation software company.The price surge appears to be driven by two positive developments. First, Barclays maintained its Overweight rating on Certara, indicating continued analyst confidence in the company's prospects. Second, Certara announced that its management will participate in several upcoming investor conferences, including the TD Cowen 46th Annual Health Care Conference, Leerink Global Healthcare Conference, and Barclays 28th Annual Global Healthcare Conference.These announcements typically generate increased investor interest and visibility for companies, potentially explaining the buying pressure that led to Certara's substantial intraday gain.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}